CN Patent

CN117801123B — 沃索利肽可溶性中间体、中间体制备方法及沃索利肽的制备方法

Assigned to Tianjin Kailaiying Biotechnology Co ltd · Expires 2024-05-03 · 2y expired

What this patent protects

本发明提供了一种沃索利肽可溶性中间体、中间体制备方法及沃索利肽的制备方法。该沃索利肽可溶性中间体包括Sumo标签蛋白、可分离位点和沃索利肽。能够解决现有技术中制备沃索利肽收率低的问题，适用于药物生物合成领域。

USPTO Abstract

本发明提供了一种沃索利肽可溶性中间体、中间体制备方法及沃索利肽的制备方法。该沃索利肽可溶性中间体包括Sumo标签蛋白、可分离位点和沃索利肽。能够解决现有技术中制备沃索利肽收率低的问题，适用于药物生物合成领域。

Drugs covered by this patent

Patent Metadata

Patent number
CN117801123B
Jurisdiction
CN
Classification
—
Expires
2024-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Kailaiying Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.